| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6081
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55577 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00117
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4727 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-04 |
| filingDate |
1997-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2001-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2001510440-A |
| titleOfInvention |
Mucin conjugate peptide vaccine |
| abstract |
(57) [Summary]nThe present invention provides a vaccine that is capable of generating an immune response that recognizes a mucin, comprising an effective amount of a mucin peptide conjugated to an immunogenic protein, to stimulate or enhance an immune response in a subject; There is provided a vaccine comprising an adjuvant and a pharmaceutically acceptable carrier. The present invention further provides a method of stimulating or enhancing the generation of an immune response that recognizes a mucin, comprising administering to a subject a vaccine as described above. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9119784-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8889616-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8871250-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8329639-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012092105-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007530663-A |
| priorityDate |
1996-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |